Nykredit A S Purchases New Position in CVS Health Corporation $CVS

Nykredit A S acquired a new stake in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,708,631 shares of the pharmacy operator’s stock, valued at approximately $280,208,000. CVS Health makes up about 0.9% of Nykredit A S’s portfolio, making the stock its 17th biggest position. Nykredit A S owned 0.21% of CVS Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Caitong International Asset Management Co. Ltd boosted its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new position in CVS Health during the 4th quarter valued at about $26,000. Kilter Group LLC purchased a new stake in shares of CVS Health during the 2nd quarter valued at about $27,000. Sankala Group LLC purchased a new stake in shares of CVS Health during the 4th quarter valued at about $28,000. Finally, Global Trust Asset Management LLC grew its stake in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 300 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.4%

Shares of CVS stock opened at $97.20 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The stock has a market cap of $124.31 billion, a P/E ratio of 25.71, a P/E/G ratio of 0.95 and a beta of 0.59. The company has a 50 day simple moving average of $101.09 and a two-hundred day simple moving average of $89.96.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter last year, the company posted $1.81 EPS. The company’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is currently 70.37%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on CVS shares. Bank of America increased their price objective on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Piper Sandler reiterated an “overweight” rating on shares of CVS Health in a research note on Wednesday, August 26th. Cantor Fitzgerald increased their price target on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, July 7th. Mizuho lifted their price objective on CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, TD Cowen upped their price objective on CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.